Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03826290 · ClinicalTrials.gov registry record · NA

Evaluation of a Dashboard for Diabetes Care Integrated With the Electronic Health Record

A NA study of Diabetes Mellitus, Type 2 and Diabetes Mellitus, sponsored by University of Utah.

Completed
Registry status
NA
Development phase
13,155
Enrollment target
1
Study location

NCT03826290 is a NA study of Diabetes Mellitus, Type 2 and Diabetes Mellitus that has completed, run by University of Utah. The registered enrollment target is 13,155 participants, above the 4,448-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (196% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03826290, a NA study of Diabetes Mellitus, Type 2 and Diabetes Mellitus, has completed, sponsored by University of Utah.

COMPLETED
Registry status
NA
Development phase
13,155 participants
Enrollment target
1
Study location

Study Summary

Diabetes is a significant medical problem in the United States and across the world. Despite significant progress in understanding how to better manage diabetes, there is oftentimes still uncertainty in the optimal management strategy for a specific patient. As a result, providers and patients must often use a trial-and-error approach to identify an effective treatment regimen. The objective of this research is to evaluate a diabetes dashboard integrated with the electronic health record (EHR) that has been developed as a collaborative project between the University of Utah and Hitachi, Ltd. This dashboard tool provides a graphical overview of the patient's relevant data parameters as well as information on the impact of different treatment options on previous patients with similar characteristics. The different treatment options compare the predicted impact of relevant medication regimens as well as weight loss. Primary care clinics are randomized to either an intervention condition where the tool is available or to a control condition where the tool is not yet available. Patients' hemoglobin A1c levels (a measure of diabetes control) are the main outcome variable. Other secondary analyses will also be conducted. Use of the tool will be encouraged but optional. Following any suggestions made in the tool will also be optional and up to the discretion of the clinician.

Interventions

  • OTHER EHR-integrated diabetes dashboard

Study Locations (1)

Utah

  • University of Utah Health - Salt Lake City

Trial Details

FieldValue
Enrollment Target 13,155 participants
Start Date 2019-01-01
Est. Completion 2020-07-01
Phase NA

Sponsor

University of Utah

818 total trials

What the Registry Record Tells You About NCT03826290

The ClinicalTrials.gov registry entry for NCT03826290 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 13,155 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 4,448-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (196% higher). The listed sponsor is University of Utah, which has 818 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Diabetes Mellitus, Type 2 appearing as the primary indexed condition, and to 1 intervention - of which EHR-integrated diabetes dashboard is the first listed.

NCT03826290 reports 1 study location spanning 1 distinct geographic area - top geographies include Utah.

Frequently Asked Questions

What is clinical trial NCT03826290 about?

NCT03826290 is a clinical study titled "Evaluation of a Dashboard for Diabetes Care Integrated With the Electronic Health Record". Diabetes is a significant medical problem in the United States and across the world. Despite significant progress in understanding how to better manage diabetes, there is oftentimes still uncertainty in the optimal management strategy for a specific patient. As a result, providers and patients must ...

What is the current status of trial NCT03826290?

This trial is currently completed. It is a NA study. The enrollment target is 13,155 participants. The study started on 2019-01-01. Estimated completion is 2020-07-01.

What conditions does trial NCT03826290 study?

This clinical trial studies the following conditions: Diabetes Mellitus, Type 2, Diabetes Mellitus.

What interventions are being tested in trial NCT03826290?

The interventions under investigation include: EHR-integrated diabetes dashboard (OTHER).

Who is sponsoring clinical trial NCT03826290?

This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03826290 being conducted?

This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Diabetes Mellitus, Type 2

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.